Affibody‐Functionalized Gold–Silica Nanoparticles for Raman Molecular Imaging of the Epidermal Growth Factor Receptor
- 8 February 2011
- Vol. 7 (5), 625-633
- https://doi.org/10.1002/smll.201002291
Abstract
The affibody functionalization of fluorescent surface‐enhanced Raman scattering gold–silica nanoparticles as multimodal contrast agents for molecular imaging specific to epidermal growth factor receptor (EGFR) is reported. This nanoparticle bioconjugate reports EGFR‐positive A431 tumors with a signal nearly 35‐fold higher than EGFR‐negative MDA‐435S tumors. The low‐level EGFR expression in adjacent healthy tissue is 7‐fold lower than in the positive tumors. Validation via competitive inhibition reduces the signal by a factor of six, and independent measurement of EGFR via flow cytometry correlates at R2 = 0.92.Keywords
This publication has 67 references indexed in Scilit:
- Understanding resistance to EGFR inhibitors—impact on future treatment strategiesNature Reviews Clinical Oncology, 2010
- Colorectal cancerThe Lancet, 2010
- Programmable Nano-Bio-Chip Sensors: Analytical Meets ClinicalAnalytical Chemistry, 2010
- Molecular Basis of Colorectal CancerNew England Journal of Medicine, 2009
- HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer TherapyChemMedChem, 2008
- Spectral Analysis of Multiplex Raman Probe SignaturesACS Nano, 2008
- Noninvasive molecular imaging of small living subjects using Raman spectroscopyProceedings of the National Academy of Sciences, 2008
- Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopyNature Medicine, 2008
- Compact Biocompatible Quantum Dots Functionalized for Cellular ImagingJournal of the American Chemical Society, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007